Rosetta Genomics Ltd. eliminated the position of chief commercial officer from the company.
As a result, the company terminated Mark Willig from employment.
Rosetta Genomics eliminates chief commercial officer position
Climate Credit Analytics: Linking climate scenarios to financial impacts
Global M&A Infographic Q1 2021
Q1 2021 Global Capital Markets Activity: SPAC IPOs, Issuance in Consumer Discretionary Sector Surge
COVID-19 Impact & Recovery: Private Equity
Rosetta Genomics eliminates chief commercial officer position
- Author Ephraim Bie
- Theme Healthcare & Pharmaceuticals